Testimonial What will make your funding application fly high and prevent it from crash-landing is ... accelopment!!
Dr. Theodossis Athanassios Theodossiou
FRINGE Project Coordinator, Lumiblast Project Partner
Oslo University Hospital, Norway

<< Projects

PCInano

Nanoparticle mediated Photochemical Internalisation (PCI) of small anticancer drugs

Current cancer chemotherapy treatments offer patients limited curative benefit as a) these need to be delivered at a minimised dose to avoid noxious or fatal side effects and b) tumour cells develop over time drug resistance resulting in drugs not having any effect on the cancerous cells anymore. In order to overcome this, drugs could be encapsulated in nanocarriers transporting to and then releasing the medicine within the tumour cells.
We will implement a novel nanoparticle-based, cancer-specific drug delivery system, allowing for controlled release upon light irradiation (PCInano). This will be implemented by parallel administration of the PCInano nanocarriers together with the light-activated agent, (photosensitiser, PS). Our nano constructs are expected to remain sequestered in the cell’s endocytic vesicles until irradiated. Upon light activation, the membrane-resident PS will rupture the endocytic vesicles and the nanocarriers’ full drug payload will be released within the target cells, free to engage vital intracellular targets.
PCInano will provide validation of the proposed technology in vitro and in vivo, primarily in difficult to cure ovarian cancer models because of the relevance to five selected drugs.
We expect the proposed technology to mature into a cost-effective and once-off cancer-specific treatment that has the potential to render the patient primary-disease free within a short time.

Coordinator:
The Radium Hospital, Oslo University Hospital, NO

Partners:

Project




AreaEnergy
ProgrammeFP7-ITN
Duration01.12.2009 - 31.11.2013
Budget3.0 million euro
More


Proposal Writing



We can support you in writing your next proposal. We are experts in proposal writing, managing the writing process with efficient time-keeping tasks and dealing with the European Commission online tools.

More

Team



Being able to support intrinsically motivated researchers and innovative companies in shaping our future while contributing to their career and business development is both fulfilling and challenging.

Dr. Jeanette Müller
CEO